PHASEBIO PHARMACEUTICALS INC's ticker is and the CUSIP is 717224909. A total of 2 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 300 | -90.3% | 0.00% | – |
| Q1 2022 | $4,000 | -88.6% | 3,100 | -77.2% | 0.00% | – |
| Q4 2021 | $35,000 | +16.7% | 13,600 | +63.9% | 0.00% | – |
| Q3 2021 | $30,000 | 0.0% | 8,300 | 0.0% | 0.00% | – |
| Q2 2021 | $30,000 | -33.3% | 8,300 | +6187.9% | 0.00% | – |
| Q1 2021 | $45,000 | +650.0% | 132 | +560.0% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 20 | +566.7% | 0.00% | – |
| Q2 2020 | $1,000 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $0 | 0.00% |